On September 1, 2021 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported that John P. Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will participate in the following schedule of investor conferences (Press release, Akebia, SEP 1, 2021, View Source [SID1234587134]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 19th Annual Global Healthcare Conference
Virtual fireside chat at 2:45 p.m. ET on September 9

H.C. Wainwright 23rd Annual Global Investment Conference
On-demand presentation available at 7:00 a.m. ET on September 13

Cantor Fitzgerald Virtual Global Healthcare Conference 2021
Virtual presentation at 2:00 p.m. ET on September 27
Where applicable, live webcasts of Akebia’s fireside chats and presentations will be made available on the Investors section of the Company’s website at View Source .